mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
TSXV market listing anticipated to improve visibility of Cannara among the investor community
MONTREAL, April 7, 2021 -Â Cannara Biotech Inc. ("Cannara") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade indoor cannabis and derivative products with one of the largest indoor cannabis cultivation faci... Read More...
Anticipated TSXV market listing coincides with the appointment of Nicholas Sosiak to CFO and retail market debut
MONTREAL, March 11, 2021 -Â Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated Quebec-based producer of premium-grade indoor cannabis and derivative products with one of the largest i... Read More...
Cannara's new product line consists of three distinct brands each filling a white space in the current cannabis market and offers something new, priced competitively and a continuous rotation of rare genetics. All three brands are grown indoors in a controlled environment, hang-dried, slow cured in barrels and hand-trimmed to preserve th... Read More...
- Cannabis Cultivation at Farnham, one of Canada's largest indoor facilities, dialed in and operational-
MONTREAL, Dec. 15, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) today announced the financial results for the three-month period and year ended August 31, 2020. Unless otherwise noted, all dollar amount... Read More...
MONTREAL, Nov. 5, 2020 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) today announced the appointment of Donald Olds as a Director on the Company's board of directors.
"Don is well recognized within the Montreal business community as a leader both within the life science sector and beyond. We are del... Read More...
MONTREAL, July 27, 2020 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF),  (FRA: 8CB), today announced financial results for the three and nine-month periods ended May 31, 2020. Unless otherwise noted, all dollar amounts are expressed in Canadian dollars.
OPERATIONAL HIGHLIGHTS
On April 20, 2020, the Company suc... Read More...
MONTREAL, July 7, 2020 -Â Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) announced today it has closed on its previously announced offer to acquire all of the issued and outstanding shares of Global shopCBD.com Inc. ("Global") not already owned by Cannara (the "Transaction").
Global, through its wholly-owned subsidi... Read More...
VANCOUVER, May 27, 2020 -Â Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis derivative products, is pleased to announce that it has entered into a proposed shar... Read More...
VANCOUVER, May 15, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative products, today announced the appointment of Mary Durocher as a Director on Cannara's Boar... Read More...
300Â kgs of Carefully Crafted Premium Indoor Cannabis Marks Pivotal Milestone
VANCOUVER, April 20, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative products, t... Read More...
Company well-financed with ample resources to reach commercial milestones in H2 2020
VANCOUVER, April 16, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative pro... Read More...
Insiders' increase stake in Cannara coincides as cultivation poised to commence
VANCOUVER, Feb. 20, 2020 -Â Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), today announced a buying group which includes Javaa Private Equity Inc. ("Javaa") has collectively acquired a total of 85,003,250 common shares from FSD/FV Pharm... Read More...
VANCOUVER, Jan. 31, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and medical sale of premium dried cannabis and cannabis derivatives under The Cannabis Act, today announced the receipt of its cultivation licence f... Read More...
VANCOUVER, Jan. 20, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-infused products, today announced financial results for the three-month period ended November 30, 20... Read More...
VANCOUVER, Nov. 26, 2019 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium cannabis and cannabis-infused products, today announced financial results for the three month period and year ended August 31, 2... Read More...
VANCOUVER, Oct. 10, 2019 - Cannara Biotech Inc. ("Cannara Biotech") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility in the value of $6 mi... Read More...
VANCOUVER, Sept. 12, 2019 - Cannara Biotech Inc. ("Cannara Biotech") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One o... Read More...
VANCOUVER, Aug. 15, 2019 - Cannara Biotech Inc. ("Cannara Biotech") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, ... Read More...
VANCOUVER, July 25, 2019 - Cannara Biotech ("Cannara") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May ... Read More...
VANCOUVER, July 12, 2019 - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares o... Read More...
VANCOUVER, May 24, 2019 - Cannara Biotech ("Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May, PhD. to the Company's Board of Directors, effective immediately. Dr. May is recognized... Read More...
VANCOUVER, May 15, 2019 - Cannara Biotech ("Cannara") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market u... Read More...
SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has entered into a Reseller Agreement with Shopcbd.com, a subsidiary of Cannara Biotech, Inc. (CSE: "LOVE") (FRA: "8CB") to market and sell Elite’s line of products withi... Read More...
VANCOUVER, April 29, 2019 - Cannara Biotech ("Cannara") (LOVE.CN) (8CB.F), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today announced financial results for the three month and six month periods ended Febru... Read More...
MONTREAL , April 8, 2019 - Cannara Biotech ("Cannara") (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leadin... Read More...
POINT ROBERTS, Wash., March 28, 2019 -- Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the rise of CBD within the overall cannabis market in the US and internationally, and how companies are preparing to deal with this explosive market.With the passing of the 2018 Farm... Read More...
MONTREAL , March 26, 2019 - Cannara Biotech Inc. ("Cannara") (LOVE.CN) (8CB.F), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15 (the ... Read More...
Quarterly rebalance includes a leading U.S.-based CBD producerTORONTO , March 18, 2019 -Â Horizons ETFs Management ( Canada ) Inc. ("Horizons ETFs") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ:TSX").Horizons ETFs Management (Canada) Inc. (CNW Group/Horizons ETFs... Read More...
MONTREAL, March 14, 2019 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara's facility from 130,000 to 170,000 square feet. As a result, the license applicati... Read More...
MONTRÉAL, Feb. 11, 2019 - Cannara Biotech Inc. ("Cannara Biotech") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol "8CB". The Company's common shares conti... Read More...
